Table 1.
Patient characteristics (n = 9)
| Risk factors/comorbidities | |
|---|---|
| Hypertension | 9 |
| Obesity | 7 |
| BMI (kg/m2) | 28.5 ± 1.4 |
| Ex‐smoker | 5 |
| Smoker | 1 |
| Diabetes mellitus | 3 |
| Renal insufficiency | 4 |
| Hyperlipidemia | 9 |
| Hyperuricemia | 4 |
| Laboratory analyses | |
| Total cholesterol (mg/dL) | 159.7 ± 6.9 |
| HDL cholesterol (mg/dL) | 47.4 ± 4.2 |
| LDL cholesterol (mg/dL) | 87.1 ± 7.2 |
| Triglycerides (mg/dL) | 180.9 ± 27.5 |
| Creatinine (mg/dL) | 1.2 ± 0.1 |
| Medications | |
| ACE inhibitors | 7 |
| AT1‐receptor antagonists | 1 |
| Beta‐blockers | 8 |
| Calcium antagonists | 4 |
| Statins | 6 |
| Diuretics | 5 |
| Antidiabetics | 5 |
| Aspirin | 9 |
| Clopidogrel | 5 |
| Prasugrel | 2 |
| Saphenous vein graft (SVG) | |
| Graft age (years) | 12.5 ± 2.0 |
| Stenosis diameter (%) | 66.0 ± 3.3 |
Continuous data are presented as mean ± SEM. ACE, angiotensin‐converting enzyme; AT1, angiotensin II type 1; BMI, body mass index; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.